类风湿关节炎对非结核分枝杆菌肺病患者呼吸相关死亡率的预后影响
本研究回顾性纳入2012至2024年新诊断的非结核分枝杆菌肺病(NTM-PD)患者1420例,其中66例(4.6%)合并类风湿关节炎(RA),55例RA起病后发生NTM-PD者与1354例无RA者比较。RA是多变量Cox分析中呼吸相关死亡的独立预测因子(HR 4.30,95%CI 2.17至8.52),RA组5年生存率显著低于非RA组(74.7% vs 92.9%,log-rank p<0.001),匹配后仍较差(p=0.029)。依次调整间质性肺病(ILD)和C反应蛋白(CRP)反映的全身炎症负荷后,RA效应出现显著衰减。
要点
- RA是NTM-PD患者呼吸相关死亡的独立预测因子(HR 4.30,95%CI 2.17至8.52)。
- RA组5年生存率74.7%,显著低于非RA组的92.9%(log-rank p<0.001)。
- 调整ILD和全身炎症负荷后RA效应衰减,提示结构性和系统性通路参与。
核心结论
- RA是NTM-PD患者呼吸相关死亡的独立预测因子,其超额风险部分由ILD和全身炎症负荷解释。
研究设计与样本
- 回顾性队列研究,纳入2012至2024年新诊断NTM-PD患者1420例,其中66例(4.6%)合并RA。
- 55例RA起病后发生NTM-PD者(RA组)与1354例无RA者(非RA组)比较,采用Cox回归和倾向评分匹配评估呼吸相关死亡。
- 采用序贯Cox回归逐步调整并量化RA效应对数风险尺度的衰减。
主要发现
- 多变量Cox分析显示RA是呼吸相关死亡的独立预测因子(HR 4.30,95%CI 2.17至8.52)。
- RA组5年生存率显著低于非RA组(74.7% vs 92.9%,log-rank p<0.001),匹配后仍较差(p=0.029)。
- 调整ILD后RA的HR从3.25降至2.44(衰减24.5%),再调整CRP反映的全身炎症负荷后降至2.09(衰减37.5%)。
关键数值与推荐
- RA组呼吸相关死亡风险HR 4.30(95%CI 2.17至8.52)。
- 5年生存率RA组74.7% vs 非RA组92.9%(log-rank p<0.001),匹配后p=0.029。
- 调整ILD后HR由3.25降至2.44(衰减24.5%),再调整CRP后降至2.09(衰减37.5%)。
临床怎么用
- 对合并RA的NTM-PD患者应识别为呼吸相关死亡高风险人群,需综合管理。
- 临床应关注ILD和全身炎症负荷(CRP)对RA合并NTM-PD患者预后的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The prognostic implications of rheumatoid arthritis (RA) in patients with non-tuberculous mycobacterial pulmonary disease (NTM-PD) remain unclear. This study aimed to evaluate the impact of RA on survival outcomes. METHODS: We conducted a retrospective cohort study of 1420 patients newly diagnosed with NTM-PD between 2012 and 2024. Among them, 66 (4.6%) had RA, including 55 who developed NTM-PD after RA onset. These 55 patients (RA group) were compared with 1354 without RA (non-RA group). Respiratory-related mortality was assessed using Cox regression and propensity score matching. To explore mechanisms underlying the excess mortality associated with RA, we conducted sequential Cox regression with stepwise adjustment and quantified attenuation of the RA effect on the log-hazard scale. RESULTS: RA was an independent predictor of respiratory-related death in multivariable Cox analysis (HR 4.30, 95% CI 2.17 to 8.52). Five-year survival was significantly lower in the RA group than in the non-RA group (74.7% vs 92.9%, log-rank p<0.001) and remained inferior after matching (p=0.029). Sequential adjustment demonstrated substantial attenuation of the RA effect after accounting for interstitial lung disease (ILD), with the HR decreasing from 3.25 to 2.44 (24.5% attenuation), and to 2.09 after adjustment for systemic inflammation burden reflected by C-reactive protein (37.5% attenuation). CONCLUSION: RA is an independent predictor of respiratory-related mortality in patients with NTM-PD. This excess risk is partly explained by ILD and systemic inflammation burden. These findings highlight structural and systemic pathways contributing to poor prognosis, underscoring the need for comprehensive management in this high-risk population.
引用
- Nii T, Hara Y, Hashimoto K, et al. Prognostic impact of rheumatoid arthritis on respiratory-related mortality in non-tuberculous mycobacterial pulmonary disease. RMD Open. 2026. PMID: 42082287. doi:10.1136/rmdopen-2026-006854
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。